Highlights Laurus Labs Limited

Equities

LAURUSLABS

INE947Q01028

Market Closed - NSE India S.E. Other stock markets 05:13:54 03/07/2024 pm IST			5-day change	1st Jan Change
436.9 ^INR	-0.19%		+2.21%	+1.56%

26/06	Willow Biosciences Provides Corporate Update and Signs New Partnered Program	MT
26/06	Willow Biosciences Brief: Announced multi-product development and licensing partnership with Laurus Labs for manufacturing active pharmaceutical ingredients	MT

Highlights

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Willow Biosciences Provides Corporate Update and Signs New Partnered Program	27/06	MT
Willow Biosciences Brief: Announced multi-product development and licensing partnership with Laurus Labs for manufacturing active pharmaceutical ingredients	27/06	MT
Willow Biosciences Signs Multi-Product Development, Licensing Partnership With Laurus Lab	30/05	MT
Willow Biosciences Inc. Announces Multi-Product Development and Licensing Partnership with Laurus Labs	30/05	CI
Granules India posts Q4 revenue fall on weak paracetamol sales, price erosion	15/05	RE
Laurus Labs' Consolidated Profit Falls in Fiscal Q4	25/04	MT
Laurus Labs Limited Approves Second Interim Dividend for the Financial Year 2023-2024, Payable on or After May 17, 2024	25/04	CI
Laurus Labs Limited Reports Earnings Results for the Full Year Ended March 31, 2024	25/04	CI
Laurus Labs Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024	25/04	CI
Laurus Labs Board to Consider Second Interim Dividend for Fiscal Year 2024	18/04	MT
Laurus Labs Incorporates New JV Company with Slovenia-Based Pharmaceutical Company	15/04	MT
Laurus Labs, Slovenia's Krka to Form JV; Laurus Shares Fall 6%	26/01	MT
Laurus Labs Limited Reaches to Agreement with Krka to Establish Joint Venture Company in Hyderabad, India Namely Krka Pharma Pvt. Ltd	25/01	CI
Laurus Labs Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	24/01	CI
Laurus Labs Completes Acquisition of Additional Stake in Laurus Bio	21/11	MT
Laurus Labs Limited completed the acquisition of additional 14.54% stake in Laurus Bio Private Limited from one of the Promoters, non-executive director, his family members and few Employee/ex-Employee shareholders.	20/11	CI
Laurus Labs Limited Approves Interim Dividend, Payable on or After November 09, 2023	20/23/20	CI
Laurus Labs Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	20/23/20	CI
Laurus Labs Limited agreed to acquire an additional 14.54% stake in Laurus Bio Private Limited from one of the Promoters, non-executive director, his family members and few Employee/ex-Employee shareholders for approximately INR 720 million.	11/23/11	CI
India's Divi's Labs Q1 profit slumps on drug pricing pressures	14/23/14	RE

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Laurus Labs Limited

Equities

LAURUSLABS

INE947Q01028

Highlights

Filters